Sleep Apnea Implants Market: Global Industry Analysis and Forecast (2023 -2029) Trends, Statistics, Dynamics, Segmentation by Product Type, Indication, End User and Region

Sleep Apnea Implants Market size was valued at USD 0.34 Bn in 2022 and the total Sleep Apnea Implants revenue is expected to grow by 15.4% from 2023 to 2029, reaching nearly USD 1.3 Bn.
Sleep Apnea Implants Market Overview:
The Sleep Apnea implants market covers the scope for the medical implantable devices used to treat obstructive sleep apnea, a condition in which a person's airway becomes partially or completely blocked during sleep, causing breathing to stop and start repeatedly.

These implants work by helping to keep the airway open during sleep. One type of sleep apnea implant is the hypoglossal nerve stimulation system. This system consists of a small device that is implanted under the skin of the chest, a breathing sensor, and a stimulation electrode that is placed around the hypoglossal nerve, which controls the movement of the tongue.

Another type of sleep apnea implant is the palate implant. This involves the insertion of small rods into the soft palate to stiffen it and prevent it from collapsing during sleep. The procedure is usually performed under local anaesthesia and takes about 30 minutes to complete. The sleep apnea implants are only recommended for people who have moderate to severe obstructive sleep apnea and have not responded to other treatments, such as continuous positive airway pressure (CPAP) therapy.

The sleep apnea implants market is experiencing significant growth and innovation in the medical device industry. This is due to a massive pool of sleep apnea incidences, which has created a market opportunity for sleep apnea implants. The growth of the sleep apnea implants market size is expected to be positively affected by the rise in demand for these devices.

Various key players across the globe are launching implant devices made up of advanced technology Emerging markets are expected to contribute significantly to the sleep apnea implants market growth due to the availability of improved healthcare infrastructure, unmet healthcare needs, and the prevalence of sleep apnea. Additionally, the development of the medical technology industry in emerging countries and the significant investments made by governments to improve healthcare infrastructure are expected to drive the growth of the sleep apnea implants market. E-commerce has become a vital tool for small and large businesses globally, further supporting the industry growth.


To know about the Research Methodology :- Request Free Sample Report
Sleep Apnea Implants Market Dynamics:
Competitive Landscape:

The competitive rivalry in the sleep apnea implants market is relatively high, with a large number of players operating in the industry. The major players are actively engaged in developing and launching new products, making strategic partnerships and collaborations, and expanding their distribution network to gain a competitive edge in the market. For instance, in September 2021, Inspire Medical Systems announced the launch of its new product, Inspire 302, a next-generation implantable neurostimulation device for the treatment of obstructive sleep apnea.

In addition, the established Sleep Apnea Implants Market leaders are investing heavily in research and development activities to introduce innovative and technologically advanced products. Furthermore, the players are also adopting various growth strategies such as mergers and acquisitions, partnerships, and collaborations to expand their market presence and increase their customer base.

For Instance, In April 2022 Inspire Medical Systems has recently announced a $10 million minority equity investment in EnsoData, a Madison-based company that has developed an FDA-approved sleep study analysis platform. This investment is expected to bolster Inspire Medical System's offerings in the sleep apnea market.

The investment will enable Inspire Medical Systems to access EnsoData's technology and expertise, which can help the company enhance its current offerings and stay ahead of its competitors in the Sleep Apnea Implants Market. Additionally, this investment highlights Inspire Medical Systems' commitment to innovation and advancing the treatment of sleep apnea, as it seeks to provide patients with more effective and personalized solutions.
Sleep Apnea Implants Market Drivers
Increasing prevalence Sleep Apnea

Sleep apnea is a common sleep disorder that affects people all over the world. According to the World Health Organization (WHO), the global prevalence of sleep apnea is estimated to be around 936 million people, or roughly 13% of the world's population. prevalence of obstructive sleep apnea, the most common type of sleep-disordered breathing, is estimated to affect around 1 billion individuals between the ages of 30 and 69 years, out of a global population of 7.3 billion people. The prevalence of mild OSA ranges from 7.8% (Hong Kong) to as high as 77.2% (Malaysia), while moderate-severe OSA affects 4.8% (Ireland and Israel) to 36.6% (Switzerland) of the population in various countries.

The prevalence of sleep apnea varies widely depending on the population studied and the diagnostic criteria used. Some studies have reported higher rates of sleep apnea in certain populations, such as older adults or those with obesity, while others have reported lower rates. The prevalence of sleep apnea is reported highest in North America, with 15 to 30 percent, males and 10 to 15 percent, women are affected by sleep apnea as of January 2023. This underscores the need for effective treatments such as sleep apnea implants to address this pervasive sleep disorder and improve patients' quality of life, creating opportunities for the sleep apnea implants market

Increasing Adoption of Minimally Invasive Surgeries Driving Sleep Apnea Implants Market

The rising prevalence of sleep apnea is leading to an increased demand for effective treatment options. As a result, the sleep apnea implants market is growing rapidly, with a significant driver being the increasing adoption of minimally invasive surgical procedures. Traditional surgical procedures for sleep apnea involve invasive surgery, which can be painful and require a long recovery time. However, the advent of minimally invasive surgical procedures has led to a shift towards these procedures, as they are associated with several benefits.

Minimally invasive surgical procedures involve small incisions, which reduces the risk of bleeding, infection, and scarring. They also require less anaesthesia, leading to a shorter recovery time, and often result in less pain and discomfort for the patient, increasing the scope for sleep apnea implants market with implants, such as hypoglossal nerve stimulation implants and palate implants, being the most adopted minimally invasive surgical options for the treatment of moderate to severe sleep apnea. These devices work by stimulating the nerves that control the tongue and other muscles in the upper airway, helping to keep the airway open during sleep.

Advances in technology have led to the development of more efficient and reliable implant devices, which are becoming more widely accepted among patients and healthcare providers. Additionally, the availability of favourable reimbursement policies for sleep apnea implants in several countries is boosting the adoption of these devices, making them more accessible to patients. Overall, the increasing adoption of minimally invasive surgical procedures is a significant driver of the sleep apnea implants market. This trend is expected to continue during the forecast period driving the market growth as more patients seek effective treatment options for sleep apnea that are less invasive and associated with fewer complication
Sleep Apnea Implants Market Segment Analysis:
Based on Product Type

By product type the sleep apnea implants market is segmented into hypoglossal neurostimulation devices, palatal implants, bone screw systems, and phrenic nerve stimulators. The Hypoglossal neurostimulation devices dominated the sleep apnea implants indsurty, accounting for a majority of the market share in 2022. This trend is expected to continue with an estimated 16.8% CAGR during the forecast period. The rapid adoption of hypoglossal neurostimulation devices can be attributed to their higher efficacy in managing obstructive sleep apnea.

Hypoglossal neurostimulation devices work by stimulating the hypoglossal nerve, which regulates the movement of tongue and airway muscles, maintaining an open airway during sleep. The technology has emerged as a therapeutic alternative for non-compliant moderate-to-severe obstructive sleep apnea patients who are unable to use conventional continuous positive airway pressure (CPAP) therapy. Other product types, such as palatal implants, bone screw systems, and phrenic nerve stimulators, are also gaining traction in the sleep apnea implant market. Palatal implants involve the insertion of small implants into the soft palate, reducing its ability to collapse and obstruct the airway. Bone screw systems are used to support the airway during sleep, while phrenic nerve stimulators stimulate the phrenic nerve, causing the diaphragm muscle to contract and expand, allowing for proper breathing during sleep.

Based on the Indication

The sleep apnea implants market is segmented based on indication, with obstructive sleep apnea (OSA) and central sleep apnea being the two main categories. Obstructive sleep apnea accounted for the highest market share in 2022, and the growing prevalence of OSA is expected to continue driving segment growth. According to a UptoDate article updated in January 2023, there are an estimated 936 million people worldwide with mild to severe OSA and 425 million people worldwide with moderate to severe OSA between the ages of 30 and 69, based on five or more events/episodes each hour.

Clinical studies and development conducted in the field of obstructive sleep apnea are anticipated to further boost demand for sleep apnea implants over the forecast period. For example, Inspire Medical Systems, Inc. sponsored a clinical study in June 2021 to evaluate the objective change in cognition and expressive language after implant and therapy with the Inspire Upper Airway Stimulation (UAS) System. These types of studies demonstrating the efficacy of different obstructive sleep apnea implants are expected to fuel sleep apnea implants market growth over the forecast period.

Based on the End User

By end user, the sleep apnea implant market is segmented into hospitals, ambulatory surgical centers, and others. The ambulatory surgical centers segment held a significant market share of more than 41% in 2021 and is projected to register a considerable CAGR during the forecast period. The dominance of this segment is attributed to the increased adoption of sleep apnea implants and implantation procedures in these healthcare facilities.

Ambulatory surgical centers offer advanced surgical technology, cutting-edge implants, and certified healthcare professionals, which drive the sleep apnea implants market expansion and preference for these facilities. Additionally, the availability and growing demand for surgical procedures at these healthcare settings for better patient care and management further fuel the growth of the sleep apnea implant market in the upcoming years.
Sleep Apnea Implants Market Regional Insights:
By region, the market is segmented in to North America, Europe, Asia Pacific , Latin America & Middle East and Africa. North America accounts for the largest market value by region due to the rising prevalence of sleep apnea in the region, which has led to an increase in the demand for sleep apnea implants. The availability of advanced healthcare infrastructure and the increasing awareness about sleep disorders are also expected to contribute to the growth of the market in the region. A study published in PubMed in March 2022 indicated that a significant number of Canadians aged above 45 are at high risk of presenting OSA, which reinforces the importance of sleep apnea implants in the region. Additionally, the University of Arizona's clinical study in August 2021 on the effects of respiratory strength training on blood pressure and cardiovascular health in adults diagnosed with moderate or severe obstructive sleep apnea highlights the need for sleep apnea implants, which is expected to drive the market growth.

In the Asia-Pacific region, the market is expected to witness the highest CAGR during the analysis period. This growth is attributed to the presence of high populace countries such as India and China, which have a high prevalence rate of sleep disorders. The increasing adoption of innovative strategies and trends by market players in the region is also expected to drive the growth of the market. The rise in awareness about the importance of early diagnosis and treatment of sleep apnea is expected to further drive the demand for sleep apnea implants in the region.
Sleep Apnea Implants Market Scope: Inquire before buying



Sleep Apnea Implants Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2017 to 2022
Market Size in 2022:
USD 0.34 Bn.


Forecast Period 2023 to 2029 CAGR:
15.4%
Market Size in 2029:
USD 1.3 Bn.


 Segments Covered:
by Product Type
Hypoglossal Neurostimulation Devices
Phrenic Nerve Stimulator
Others


by Indication
Obstructive Sleep Apnea
Central Sleep Apnea


by End User
Hospitals
Ambulatory Surgery Centers
Others



Key Players
1. Inspire Medical Systems, Inc.
2. Medtronic plc
3. LivaNova PLC
4. Respicardia, Inc.
5. ImThera Medical, Inc.
6. Nyxoah SA
7. Zephyr Sleep Technologies Inc.
8. Nihon Kohden Corporation
9. Compumedics Limited
10.Itamar Medical Ltd.
11.Fisher & Paykel Healthcare Corporation Limited
12.Philips Respironics (a subsidiary of Koninklijke Philips N.V.)
13.SomnoMed Ltd.
14.Braebon Medical Corporation
15.Apnex Medical, Inc.
16.Provent Sleep Therapy LLC
17.Vivos Therapeutics, Inc.
18.SomnoSure GmbH
19.Airway Management Inc.
20.Sleep Apnea Sciences Corporation

Frequently Asked Questions:

1] What segments are covered in the Global Sleep Apnea Implants Market report?
Ans. The segments covered in the Market report are based on Product Type, Indication, End Users and Region.

2] Which region is expected to hold the highest share in the Global Sleep Apnea Implants Market?
Ans. The North America region is expected to hold the highest share of the  Market.

3] What is the market size of the Sleep Apnea Implants Market by 2029?
Ans. The market size of the Market by 2029 is expected to reach US$ 1.3 Bn.

4] What is the forecast period for the Global Sleep Apnea Implants Market?
Ans. The forecast period for the Market is 2023-2029.

5] What was the market size of the Sleep Apnea Implants Market in 2022?
Ans. The market size of the  Market in 2022 was valued at USD 0.3 Bn.